Original language | English |
---|---|
Pages (from-to) | S354-S355 |
Journal | ANNALS OF ONCOLOGY |
Volume | 34 |
DOIs | |
Publication status | Published - 2023 |
Treatment of elderly patients (pts; > 75 years) with 1st-line ribociclib (RIB) plus endocrine therapy (ET) or endocrine monotherapy in clinical routine: Real-world data from the RIBANNA study (5th interim analysis (IA))
T Decker, C Brucker, P Fasching, T Göhler, C Jackisch, J Janssen, A Koehler, K Luedtke-Heckenkamp, D Lüftner, M Van Mackelenbergh, F Marmé, A Nusch, B Rautenberg, T Reimer, M Schmidt, R Weide, P Wimberger, SM Figueroa, C Roos, A Woeckel
Research output: Contribution to journal › published Abstract (Journal) › peer-review